New immunotherapy trial for advanced sarcoma: Researchers at the University of Texas MD Anderson Cancer Center, Houston, are conducting a trial to evaluate neoadjuvant checkpoint blockade in patients with surgically resectable soft tissue sarcoma ( Identifier: NCT03307616). The study is evaluating neoadjuvant nivolumab and ipilimumab in combination plus concurrent neoadjuvant radiation therapy